| 000 | 01468 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513064552.0 | ||
| 264 | 0 | _c19940707 | |
| 008 | 199407s 0 0 eng d | ||
| 022 | _a0251-1649 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMessa, G L | |
| 245 | 0 | 0 |
_aAction of 2-acetoxy-trifluoromethylbenzoic acid (Triflusal) on platelet function after repeated oral administration in man: a pharmacological clinical study. _h[electronic resource] |
| 260 |
_bInternational journal of clinical pharmacology research _c1993 |
||
| 300 |
_a263-73 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_a6-Ketoprostaglandin F1 alpha _xblood |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBlood Platelet Disorders _xprevention & control |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aPlatelet Factor 3 _xanalysis |
| 650 | 0 | 4 |
_aPlatelet Factor 4 _xanalysis |
| 650 | 0 | 4 |
_aSalicylates _xadministration & dosage |
| 650 | 0 | 4 |
_aThromboxane B2 _xblood |
| 650 | 0 | 4 |
_abeta-Thromboglobulin _xanalysis |
| 700 | 1 | _aFranchi, M | |
| 700 | 1 | _aAuteri, A | |
| 700 | 1 | _aDi Perri, T | |
| 773 | 0 |
_tInternational journal of clinical pharmacology research _gvol. 13 _gno. 5 _gp. 263-73 |
|
| 999 |
_c8200029 _d8200029 |
||